Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for AdaptHealth Corp. (AHCO:NASDAQ), powered by AI.
AdaptHealth Corp. is currently trading at $10.14. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for AdaptHealth Corp. on Alpha Lenz.
AdaptHealth Corp.'s P/E ratio is -19.4.
“AdaptHealth Corp. trades at a P/E of -19.4 (undervalued) with modest ROE of -4.6%.”
Ask for details →AdaptHealth Corp. is a healthcare services company specializing in the distribution of home medical equipment and respiratory products in the United States. Focused on improving patient quality of life, it offers a comprehensive suite of services that includes home delivery, set-up, and patient education, primarily for patients requiring home-based therapy for chronic or acute conditions. AdaptHealth serves a wide range of sectors including home health, skilled nursing facilities, and retail establishments. Notable features of AdaptHealth's offerings include advanced respiratory equipment like CPAP devices, home oxygen therapy systems, and mobility accessories such as wheelchairs and walkers. In the healthcare market, AdaptHealth plays a critical role by bridging the gap between healthcare providers and patients, ensuring timely delivery of essential medical equipment to homes. Headquartered in Plymouth Meeting, Pennsylvania, the company continues to expand its reach across the nation, collaborating with health systems and insurance providers to streamline patient care in the home setting.
“AdaptHealth Corp. trades at a P/E of -19.4 (undervalued) with modest ROE of -4.6%.”
Ask for details →AdaptHealth Corp. (ticker: AHCO) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 10,500 employees. Market cap is $1.4B.
The current price is $10.14 with a P/E ratio of -19.36x and P/B of 0.9x.
ROE is -4.58% and operating margin is 5.74%. Annual revenue is $3.2B.